High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities

被引：0
|
作者：
Ioannis A. Voutsadakis
机构：
[1] Algoma District Cancer Program,Section of Internal Medicine, Division of Clinical Sciences
[2] Sault Area Hospital,undefined
[3] Northern Ontario School of Medicine,undefined
来源：
Targeted Oncology | 2020年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 138
页数：11
相关论文
共 50 条
  • [21] Effective Value of Tumor Mutation Burden (TMB) for Therapeutic Efficacy of Pembrolizumab in Breast Cancer
    Kawabata, Kyoka
    Nishikubo, Hinano
    Imanishi, Daiki
    Sakuma, Takashi
    Maruo, Koji
    Ma, Dongheng
    Tsukada, Yuki
    Yamamoto, Yurie
    Fan, Canfeng
    Yashiro, Masakazu
    CANCER SCIENCE, 2025, 116 : 925 - 925
  • [22] Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
    Ribeiro, Rita
    Carvalho, Maria Joao
    Goncalves, Joao
    Moreira, Joao Nuno
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [23] Tumor Mutation Burden Through Hybrid Capture - Circulating Tumor DNA May Predict Response to Immunotherapy in NSCLC
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Lanman, R.
    Mehta, D.
    Kiedrowski, L.
    Raez, L.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S459 - S459
  • [24] TUMOR PROLIFERATION INDEX - ITS VALUE FOR PREDICTIVITY OF THERAPEUTIC RESPONSE IN BREAST CANCERS
    MAGDELENAT, H
    REMVIKOS, Y
    VIELH, P
    PATHOLOGIE BIOLOGIE, 1990, 38 (08): : 780 - 781
  • [25] High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
    Ping Mei
    C. Eric Freitag
    Lai Wei
    Yunxiang Zhang
    Anil V. Parwani
    Zaibo Li
    Diagnostic Pathology, 15
  • [26] High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
    Mei, Ping
    Freitag, C. Eric
    Wei, Lai
    Zhang, Yunxiang
    Parwani, Anil, V
    Li, Zaibo
    DIAGNOSTIC PATHOLOGY, 2020, 15 (01)
  • [27] Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
    Yuan Li
    Zuhua Chen
    Weiping Tao
    Nan Sun
    Jie He
    Cancer Immunology, Immunotherapy, 2021, 70 : 2367 - 2378
  • [28] Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
    Li, Yuan
    Chen, Zuhua
    Tao, Weiping
    Sun, Nan
    He, Jie
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (08) : 2367 - 2378
  • [29] Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer
    Li, Y.
    Chen, Z.
    Wu, L.
    Tao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S724 - S724
  • [30] MDN1 Mutation Is Associated With High Tumor Mutation Burden and Unfavorable Prognosis in Breast Cancer
    Hao, Shuai
    Huang, Miao
    Xu, Xiaofan
    Wang, Xulin
    Huo, Liqun
    Wang, Lu
    Gu, Jun
    FRONTIERS IN GENETICS, 2022, 13
12345